Current use and developments needed for optimal design in pharmacometrics: A study performed among ddmore's european federation of pharmaceutical industries and associations members

F. Mentré, M. Chenel, E. Comets, J. Grevel, A. Hooker, M. O. Karlsson, M. Lavielle, I. Gueorguieva

Research output: Contribution to journalReview articlepeer-review

Abstract

Methods and software tools for optimal design in nonlinear mixed effect models, based on the Fisher information matrix, have been developed for a decade.1,2 Academic groups regularly proposed new versions.3-5 Present tools do not incorporate adaptive designs for these models although prior information is needed and adaptive designs are increasingly used in drug development.6 We conducted a study among drug companies of the Drug and Disease Model Resources consortium7 to identify current practices and expectations.

Original languageEnglish
Article numbere46
JournalCPT: Pharmacometrics and Systems Pharmacology
Volume2
Issue number6
DOIs
Publication statusPublished - 1 Jun 2013
Externally publishedYes

Fingerprint

Dive into the research topics of 'Current use and developments needed for optimal design in pharmacometrics: A study performed among ddmore's european federation of pharmaceutical industries and associations members'. Together they form a unique fingerprint.

Cite this